Pharmacy News

FDA grants fast track approval for OTC nasal spray

FDA has reportedly put an OTC version of naloxone nasal spray (Narcan—Emergent BioSolutions) on the fast track to approval.

Recovering COVID patients seem to have elevated risk for newly diagnosed diabetes

A study in BMC Medicine found that people recovering from COVID-19 are at higher risk of being newly diagnosed with diabetes.

Shingles may increase risk for stroke, heart attack

A new study published in the Journal of the American Heart Association found that shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of major cardiovascular events such as stroke or heart attack.

Study questions HDLs in predicting CVD risk

A new study in the Journal of the American College of Cardiology reported that HDL, typically regarded as “good cholesterol,” might not be as universally useful for determining people’s CVD risk as previously thought by researchers.

Study finds benzodiazepines for sleep increased overdose risk for young adults

New findings from a recent study in JAMA Network Open suggest that benzodiazepines—compared with alternative pharmacologic treatments for common sleep disorders—were associated with an increased risk of drug overdose among young people, especially those with a recent opioid prescription.